Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 18 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Electronic device and recording medium
Multi-chip package with a supporting member and method of manufacturing the same
2,4-disubstituted pyrimidines useful as kinase inhibitors
Emergency power-off button with proximity alarm
Method for parking or exiting a parking bay and for avoiding a collision of a vehicle, and corresponding assistance systems and vehicle
Dynamic data filtering system and method
Systems and related methods of user-guided searching
  Randomly Featured Patents
Pulse duration modulator and pulse duration modulation type switching power source
Method and system for preventing vehicle misfuelling
Polynucleotide compositions for intramuscular administration
Mixing nozzle for two reactant components
Landing zone inertial latch
Vascular-preferred promoter sequences and uses thereof
Lead-bond type chip package and manufacturing method thereof
System and method of communicating emergency alerts
Mismatched filters for long binary codes